

PhaseRx is a startup company focused on the delivery of siRNA and other macromolecular therapeutics for the treatment of orphan diseases. Among its major competitors, PhaseRx is ranked in 8th place for NPS while Biogen is 1st, and Emergent Biosolutions is 2nd.